While many of these 182 publications investigated various situations/conditions that regulated different biological effects in renal cancer through p53 signaling such as these cited here [124–128], we will have a closer review of the p53/TP53’s role acting as a biomarker and/or therapeutic targets in renal/kidney cancer. Here, TP53 is linked to renal carcinoma.